GPX1 rs1050450: What Your Genotype Means
The rs1050450 variant is a common genetic change in the GPX1 gene that results in a substitution of the amino acid proline for leucine. This variant is studied for its potential influence on the activity of the glutathione peroxidase 1 enzyme, which helps the body manage oxidative stress.
What each genotype means
Standard enzyme activity
This genotype represents the most common form of the GPX1 gene, often referred to as the Pro198 variant. Research suggests individuals with this genotype may have higher baseline glutathione peroxidase 1 enzyme activity compared to those carrying the T allele, potentially offering more robust protection against oxidative stress.
This is the most common genotype in most global populations, particularly in European and East Asian ancestries.
Intermediate enzyme activity
This genotype is a heterozygous state, carrying one copy of the standard C allele and one copy of the T allele, also known as the Leu198 variant. Research indicates that this combination may result in intermediate levels of GPX1 enzyme activity, which can influence how your body manages oxidative stress during physical exertion.
This genotype is frequently observed, appearing in a significant portion of the population across various ethnic groups.
Reduced enzyme activity
This genotype consists of two copies of the T allele, which is associated with reduced glutathione peroxidase 1 enzyme function. Some studies suggest this may lead to a decreased capacity to neutralize oxidative stress, though the clinical significance remains a subject of ongoing research and is likely influenced by selenium status.
This is the minor genotype, occurring less frequently than the CC or CT genotypes in most populations, with a higher prevalence in European compared to East Asian ancestries.
Understanding the rs1050450 Variant
The rs1050450 variant is a single nucleotide polymorphism (SNP) located within the GPX1 gene on chromosome 3. Specifically, it involves a cytosine-to-thymine substitution at codon 198. This change leads to a missense mutation where the amino acid proline is replaced by leucine in the resulting protein structure. Because this alteration occurs in the coding region of the gene, it is classified as a protein-altering variant. Researchers have extensively investigated this site because the GPX1 protein is a critical component of the body's antioxidant defense system. By changing the primary sequence of the enzyme, this variant may influence how the protein folds or interacts with its substrates, potentially impacting its overall efficiency in neutralizing reactive oxygen species within cells.
The Role of the GPX1 Gene
The GPX1 gene encodes glutathione peroxidase 1, an enzyme that plays a vital role in protecting cells from oxidative damage. This enzyme is selenium-dependent, meaning it requires the trace mineral selenium to function correctly. Its primary job is to catalyze the reduction of hydrogen peroxide and other organic hydroperoxides into water or corresponding alcohols, thereby preventing the accumulation of harmful free radicals. By maintaining this balance, GPX1 helps protect cellular components like lipids, proteins, and DNA from oxidative stress. Because oxidative stress is a factor in many physiological processes and chronic conditions, variations in the GPX1 gene that alter enzyme activity are of significant interest to researchers studying human health, metabolism, and the body's response to environmental stressors.
Research Associations and Evidence Strength
Research into rs1050450 has produced mixed and sometimes conflicting results regarding its clinical impact. Some studies suggest that the leucine (T) allele is associated with reduced enzymatic activity and lower structural stability compared to the proline (C) allele, which may theoretically weaken the body's ability to combat oxidative stress. Meta-analyses have explored links between this variant and various health outcomes, including cancer susceptibility and metabolic syndrome, with some findings indicating a modest increase in risk for specific conditions. However, the evidence remains limited and inconsistent across different populations and study designs. It is important to note that genetic associations are statistical in nature and do not imply a direct cause-and-effect relationship for any individual. Much of the current research is observational, and more robust, large-scale studies are needed to clarify the functional significance of this variant in diverse human populations.
Population Frequency
The frequency of the rs1050450 variant varies significantly across different ancestral groups. According to data from the gnomAD database and the 1000 Genomes Project, the minor allele (T) is most common in European populations, with frequencies often reported around 0.30 to 0.33. In contrast, the frequency is notably lower in East Asian populations, where it is approximately 0.07 to 0.08. Other populations, such as those of African or South Asian ancestry, show intermediate frequencies. These differences highlight the importance of considering genetic background when interpreting research findings, as the prevalence of a specific genotype can differ widely depending on one's heritage.
Interpreting Your Genetic Information
If you have access to your genetic data regarding rs1050450, it is important to understand that this information is for educational purposes only. The presence of a specific genotype does not constitute a medical diagnosis or a prediction of future health. Because the scientific evidence linking this variant to specific health outcomes is mixed and often limited, it should not be used to make decisions about your lifestyle, diet, or medical care. If you have concerns about your health, oxidative stress, or nutritional status, the best course of action is to consult with a qualified healthcare professional or a registered dietitian. They can provide personalized guidance based on your overall health history, clinical symptoms, and standard diagnostic testing, rather than relying on a single genetic marker.
How common is this variant?
The minor allele (T) frequency is approximately 0.30 in European populations and 0.08 in East Asian populations, reflecting significant ancestral diversity.
Frequently asked questions
What does the GPX1 rs1050450 variant do?
The rs1050450 variant is a genetic change that alters the structure of the GPX1 enzyme. This enzyme is responsible for neutralizing oxidative stress in the body, and the variant may influence how efficiently the enzyme performs this task.
Is the rs1050450 variant dangerous?
No, this variant is a common genetic polymorphism found in many healthy individuals. While some research explores its potential link to health risks, it is not considered a disease-causing mutation.
Should I take selenium supplements if I have the TT genotype?
You should not make changes to your diet or supplement regimen based on this genetic variant. Please discuss your nutritional needs and any potential supplementation with your doctor or a registered dietitian.
Where can I find more information about my specific genotype?
You can look up your specific rsID in public databases like the NCBI SNP database or Ensembl. However, always interpret these results in the context of your overall health and consult a professional for medical advice.
Sources & further reading
Educational information only, last refreshed 10/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1050450?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29